Singapore markets open in 7 hours 11 minutes
Straits Times Index
3,290.70 +24.75 (+0.76%) S&P 500
5,222.68 +8.60 (+0.16%) Dow
39,512.84 +125.04 (+0.32%) Nasdaq
16,340.87 -5.43 (-0.03%) Bitcoin USD
61,473.38 +346.72 (+0.57%) CMC Crypto 200
1,269.70 -88.31 (-6.50%)
Quest Diagnostics Incorporated (DGX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 138.16 |
| Open | 138.12 |
| Bid | 128.91 x 900 |
| Ask | 143.57 x 1100 |
| Day's range | 137.40 - 138.94 |
| 52-week range | 119.59 - 145.58 |
| Volume | |
| Avg. volume | 976,075 |
| Market cap | 15.377B |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | 18.63 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.00 (2.17%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | N/A |
- Zacks
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
- Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
© 2024 Yahoo. All rights reserved.